<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03388086</url>
  </required_header>
  <id_info>
    <org_study_id>2017-17</org_study_id>
    <nct_id>NCT03388086</nct_id>
  </id_info>
  <brief_title>Efficacy of Two Onabotulinum Toxin Doses</brief_title>
  <official_title>Comparing the Efficacy of Two Doses of Onabotulinum Toxin for the Treatment of Neurogenic Detrusor Overactivity - a Retrospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Paraplegic Centre Nottwil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Swiss Paraplegic Centre Nottwil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The changes in bladder function after the injection of Onabotulinum toxin into the detrusor
      in individuals with neurogenic bladder overactivity will be investigated retrospectively. The
      records of all patients treated with Onabotulinum toxin injections into the detrusor since
      2000 will be evaluated. The changes in the urodynamic values after the injection of 300 units
      of Onabotulinum toxin will be compared with the changes after the injection of 200 units.
      Furthermore, the differences in urinary continence, duration between injections, side effects
      and complications between the two groups will be investigated.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change in detrusor pressure post-injection</measure>
    <time_frame>within 3 months before injection; within 2 months after injection</time_frame>
    <description>bladder detrusor pressure during storage phase</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>maximum bladder volume</measure>
    <time_frame>within 3 months before injection; within 2 months after injection</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bladder compliance</measure>
    <time_frame>within 3 months before injection; within 2 months after injection</time_frame>
    <description>The relationship between a change in bladder volume and the change in detrusor pressure (ΔDV/ΔDP).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>reflexive bladder volume</measure>
    <time_frame>within 3 months before injection; within 2 months after injection</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>within 2 months after injection</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence of urinary incontinence</measure>
    <time_frame>within 3 months before injection; within 2 months after injection</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>lesion level</measure>
    <time_frame>at the time of spinal cord injury</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>lesion severity</measure>
    <time_frame>at the time of spinal cord injury</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>method of bladder evacuation</measure>
    <time_frame>within 2 months after injection</time_frame>
    <description>evacuation by intermittent catheterization, reflex voiding, suprapubic catheter , electric stimulation</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Neurogenic Bladder</condition>
  <condition>Overactive Detrusor</condition>
  <arm_group>
    <arm_group_label>Onabotulinum 300 units</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Onabotulinum 200 units</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Injection of Onabotulinum toxin</intervention_name>
    <description>multiple injections of Onabotulinum toxin into the detrusor muscle</description>
    <arm_group_label>Onabotulinum 300 units</arm_group_label>
    <arm_group_label>Onabotulinum 200 units</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients treated with Onabotulinum toxin for neurogenic detrusor overactivity as a result
        of spinal cord injury
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  neurogenic detrusor overactivity

          -  spinal cord injury

          -  Onabotulinum toxin injections into the detrusor from 2000-2017

        Exclusion Criteria:

          -  missing urodynamic values before or after Onabotulinum toxin injections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Swiss Paraplegic Centre</name>
      <address>
        <city>Nottwil</city>
        <state>LU</state>
        <zip>6207</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2017</study_first_submitted>
  <study_first_submitted_qc>December 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 2, 2018</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder, Neurogenic</mesh_term>
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

